| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |